Last reviewed · How we verify
NCT06137989
Clinical Performance of Dual- and Light-cure Bulk-fill Resin Composites
NA trial testing Fill-Up Class ӀӀ restoration in Dental Caries Class II in 40 participants. Completed in 30 August 2022.
20 August 2022
Quick facts
| Lead sponsor | Mansoura University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 4 August 2020 |
| Primary completion | 20 August 2022 |
| Estimated completion | 30 August 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Fill-Up Class ӀӀ restoration
- QuiXfil Class ӀӀ restoration
- Tetric N-Ceram Bulk Fill Class ӀӀ restoration
Conditions studied
- Dental Caries Class II — all drugs for Dental Caries Class II →
Sponsor
Mansoura University
Who can join
Adults 21 to 50, any sex, with Dental Caries Class II. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study (a double-blinded, prospective, randomized clinical trial) aimed to evaluate 2-year clinical performance of dual- and light-cure bulk-fill resin composites in Class ӀӀ restorations. The null hypothesis tested in this study was that, there would be no difference in the 2-year clinical performance of all tested bulk-fill resin composites in Class II restorations. Forty patients were enrolled in the study. Each patient received three bulk-fill resin composites Class ӀӀ restorations. One dual-cure and two light-cure bulk-fill resin composites were used for Class ӀӀ restorations following manufacturer's instructions. A universal adhesive was used with all restorations. All restorations were clinically evaluated after 1 week (baseline), 6 months, 12 months, 18 months and finally after 24 months using the FDI World Dental Federation criteria.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Two-year clinical performance of dual- and light-cure bulk-fill resin composites in Class ӀӀ restorations: a randomized clinical trial.
Elawsya ME, Montaser MA, El-Wassefy NA, Zaghloul NM. · · 2024 · cited 7× · PMID 38321228 · DOI 10.1007/s00784-024-05538-0
Verify or expand the search:
- PubMed search for NCT06137989
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dental Caries Class II
Currently open trials in the same condition.
- NCT06563128 — Clinical Success of Single-Color Universal Resin Composites · NA · active not recruiting
- NCT06265116 — One-Step Universal Adhesives: A 3-year Clinical Trial in Class II Composite Restorations · NA · active not recruiting
- NCT06833528 — Clinical Performance of Novel Alkasite Restorative Material "Cention Forte" in Class II Restorations · NA · active not recruiting
Other Mansoura University trials
Trials by the same sponsor.
- NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
- NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
- NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
- NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
- NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06137989 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mansoura University
- Last refreshed: 18 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06137989.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing